Frontlight ResearchEarly access
CompletedNo phase
Early Detection of PDAC in Patients With Chronic Pancreatitis
Key facts
- Who runs it
- First Affiliated Hospital Xi'an Jiaotong University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 359 people enrolled
- Started
- 1 Aug 2024
- Ended
- 1 Dec 2024
- Type of study
- Observational
- Treatments tested
- histopathological confirmation
- Record updated
- 5 August 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- a confirmed diagnosis of chronic pancreatitis; (2) availability of pathological confirmation
Who cannot take part
- age less than 18 years; (2) ambiguous pathology, including cases with only cytological findings or indications of pancreatic tissue alone; (3) preoperative diagnosis of PDAC or other pancreatic tumors before invasive procedure; (4) presence of tumors in other organs; (5) patients with missing data exceeding 15% of the total dataset
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this study is to find simple warning signs that doctors can use to spot pancreatic cancer early in people who have chronic pancreatitis.
Treatments tested
- histopathological confirmation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- High Efficiency of Early Detection of Synchronous Pancreatic Ductal Adenocarcinoma in Patients With Chronic Pancreatitis
- Record updated
- 5 August 2025